Snowden Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$428K Buy
5,165
+323
+7% +$26.8K 0.01% 842
2025
Q1
$393K Buy
+4,842
New +$393K 0.01% 860
2024
Q4
Sell
-5,099
Closed -$504K 1270
2024
Q3
$504K Sell
5,099
-139
-3% -$13.7K 0.02% 769
2024
Q2
$486K Sell
5,238
-2,426
-32% -$225K 0.01% 765
2024
Q1
$727K Sell
7,664
-423
-5% -$40.1K 0.02% 601
2023
Q4
$722K Buy
8,087
+1,147
+17% +$102K 0.03% 536
2023
Q3
$507K Sell
6,940
-648
-9% -$47.3K 0.02% 648
2023
Q2
$631K Buy
7,588
+1,957
+35% +$163K 0.02% 626
2023
Q1
$429K Sell
5,631
-1,849
-25% -$141K 0.02% 795
2022
Q4
$621K Buy
7,480
+2,200
+42% +$183K 0.03% 616
2022
Q3
$418K Sell
5,280
-1,797
-25% -$142K 0.02% 724
2022
Q2
$525K Buy
7,077
+1,039
+17% +$77.1K 0.02% 606
2022
Q1
$542K Buy
6,038
+1,721
+40% +$154K 0.02% 608
2021
Q4
$483K Sell
4,317
-1,031
-19% -$115K 0.02% 459
2021
Q3
$672K Sell
5,348
-220
-4% -$27.7K 0.03% 460
2021
Q2
$754K Sell
5,568
-3,091
-36% -$419K 0.04% 436
2021
Q1
$1.17M Buy
8,659
+69
+0.8% +$9.36K 0.07% 306
2020
Q4
$1.21M Sell
8,590
-2,550
-23% -$359K 0.08% 279
2020
Q3
$1.24M Buy
11,140
+4,282
+62% +$477K 0.1% 234
2020
Q2
$768K Buy
6,858
+122
+2% +$13.7K 0.07% 295
2020
Q1
$522K Sell
6,736
-2,547
-27% -$197K 0.06% 335
2019
Q4
$883K Sell
9,283
-170
-2% -$16.2K 0.08% 290
2019
Q3
$721K Sell
9,453
-4,169
-31% -$318K 0.07% 292
2019
Q2
$1.19M Sell
13,622
-684
-5% -$60K 0.12% 229
2019
Q1
$1.3M Buy
14,306
+3,698
+35% +$335K 0.14% 219
2018
Q4
$761K Sell
10,608
-10,803
-50% -$775K 0.1% 261
2018
Q3
$2.05M Buy
21,411
+258
+1% +$24.7K 0.23% 141
2018
Q2
$2.01M Buy
21,153
+430
+2% +$40.9K 0.26% 120
2018
Q1
$1.82M Buy
20,723
+712
+4% +$62.5K 0.27% 128
2017
Q4
$1.7M Buy
20,011
+3,567
+22% +$303K 0.24% 137
2017
Q3
$1.42M Buy
+16,444
New +$1.42M 0.23% 142